SPOTLIGHT: Finance chiefs fleeing from biopharmas

ImClone System's finance-meister is jumping ship, the company announced. And no, it's not your imagination--Ana Stancic's departure will make ImClone the sixth biopharma company to lose its finance chief in recent months. FiercePharma